Clinical Trial Update: To Evaluate the Efficacy of CT041 in Sequential Treatment After First-line Treatment of Advanced Gastric/Esophagogastric Junction Adenocarcinoma

View source ↗

Summary

A clinical trial evaluating the efficacy of CT041 in sequential treatment after first-line therapy for advanced gastric cancer and gastroesophageal junction ade…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer
• Gastroesophageal Junction Adenocarcinoma

Drugs mentioned

• CT041 (Claudin18.2-targeted CAR-T cell therapy)

Snippet

Sponsor: Beijing GoBroad Hospital | Conditions: Gastroesophageal Junction Adenocarcinoma | Status: RECRUITING